Replies to post #236305 on Biotech Values

[DewDiligence]

VIRI -71% on phase-2b failure in fibromyalgia:

https://finance.yahoo.com/news/virios-therapeutics-announces-top-line-110500583.html

My comment from 12/16/20:

...the company itself admits that such conditions as fibromyalgia are poorly understood, so who knows if Virios is even chasing the right targets.